The present work aims to understand the crystallographic basis of the mechanical behavior
of rivaroxaban-malonic acid cocrystal (RIV-MAL Co) in comparison to its parent constituents …

Rivaroxaban is one of the most prescribed anticoagulants. The ingestion of the correct
dosage is a key to the success of the therapy. A procedure to evaluate the content of active …

Objective: In the present work, RP-HPLC procedure is optimized to finalize a different
approach for the estimation of rivaroxaban in tablet dosage form. A novel drug rivaroxaban …

In this study, we have directly incorporated nanographene oxide (nGO) into a hydrophobic
drug for enhanced dissolution performance through an antisolvent technique. Apixaban …

Rivaroxaban is oral anti-coagulant drug, used in the treatment of various blood disorders. A
sensitive and accurate liquid chromatographic methodfor the quantification of rivaroxaban in …

Nanonization has been extensively investigated to increase the oral bioavailability of
hydrophobic drugs in general and antiretrovirals (ARVs) used in the therapy of the human …

An isocratic reversed phase high-performance liquid chromatography coupled with a photo
diode array and electrospray ionization tandem mass spectrometry (LC-PDA-ESI-MS/MS) …

Abstract What is Known and Objective Although predictable pharmacokinetic and
pharmacodynamic of rivaroxaban allow fixed dosing regimens without routine coagulation …

According to the literature, the pharmacokinetic profile of RIV in healthy subjects has been
established and demonstrated a favourable safety and tolerability profile. By the …

The objective of this study was to demonstrate the bioequivalence of 2 oral tablet
formulations of rivaroxaban 20 mg in healthy Mexican volunteers under fed conditions. This …